Search / 691 results found

from
to
  • Updated

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 17 to 21, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

FRIDAY, Jan. 21, 2022 (HealthDay News) -- Vaccine effectiveness against symptomatic COVID-19 decreases by 20 weeks after the second dose of BNT162b2 or CHAdOx1-S, but limited waning is seen against COVID-19-related hospitalization and death, according to a study published online Jan. 12 in the New England Journal of Medicine.

  • Updated

FRIDAY, Jan. 21, 2022 (HealthDay News) -- Biosimilar drugs could drive down prices for biologic drugs and generate savings of about $38.4 billion between 2021 and 2025, according to a study published online Jan. 3 in the American Journal of Managed Care.

FRIDAY, Jan. 21, 2022 (HealthDay News) -- The risk of hospitalization for COVID-19 among older Americans is far higher for those who are unvaccinated than for those who are fully vaccinated and have had a booster shot, new government data shows.

  • Updated

THURSDAY, Jan. 20, 2022 (HealthDay News) -- Having a child with type 1 diabetes can be a challenging health condition for parents to manage, but new research suggests an "artificial pancreas" system may beat standard treatment in controlling the blood sugar disease in young children.